128 related articles for article (PubMed ID: 37688410)
1. Detection of mesenchymal chondrosarcoma in pleural effusion with immunocytochemistry and determination of HEY1::NCOA2 fusion by next-generation sequencing on cell block.
Zhong J; Wang Q; Xie Y; Niu Z; Zhou D
Cytopathology; 2024 Jan; 35(1):149-152. PubMed ID: 37688410
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal chondrosarcoma diagnosed on FISH for HEY1-NCOA2 fusion gene.
Moriya K; Katayama S; Onuma M; Rikiishi T; Hosaka M; Watanabe M; Hasegawa T; Sasahara Y; Kure S
Pediatr Int; 2014 Oct; 56(5):e55-7. PubMed ID: 25336010
[TBL] [Abstract][Full Text] [Related]
3. Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis.
Qi W; Rosikiewicz W; Yin Z; Xu B; Jiang H; Wan S; Fan Y; Wu G; Wang L
J Pathol; 2022 Aug; 257(5):579-592. PubMed ID: 35342947
[TBL] [Abstract][Full Text] [Related]
4. Are meningeal hemangiopericytoma and mesenchymal chondrosarcoma the same?: a study of HEY1-NCOA2 fusion.
Fritchie KJ; Jin L; Ruano A; Oliveira AM; Rubin BP
Am J Clin Pathol; 2013 Nov; 140(5):670-4. PubMed ID: 24124145
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data.
Wang L; Motoi T; Khanin R; Olshen A; Mertens F; Bridge J; Dal Cin P; Antonescu CR; Singer S; Hameed M; Bovee JV; Hogendoorn PC; Socci N; Ladanyi M
Genes Chromosomes Cancer; 2012 Feb; 51(2):127-39. PubMed ID: 22034177
[TBL] [Abstract][Full Text] [Related]
6. Detection of HEY1-NCOA2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma.
Nakayama R; Miura Y; Ogino J; Susa M; Watanabe I; Horiuchi K; Anazawa U; Toyama Y; Morioka H; Mukai M; Hasegawa T
Pathol Int; 2012 Dec; 62(12):823-6. PubMed ID: 23252872
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic involvement by mesenchymal chondrosarcoma harboring the HEY1-NCOA2 gene fusion.
Cohen JN; Solomon DA; Horvai AE; Kakar S
Hum Pathol; 2016 Dec; 58():35-40. PubMed ID: 27544802
[TBL] [Abstract][Full Text] [Related]
8. Minute mesenchymal chondrosarcoma within osteochondroma: an unexpected diagnosis confirmed by HEY1-NCOA2 fusion.
Toki S; Motoi T; Miyake M; Kobayashi E; Kawai A; Yoshida A
Hum Pathol; 2018 Nov; 81():255-260. PubMed ID: 29596896
[TBL] [Abstract][Full Text] [Related]
9. Novel low-grade renal spindle cell neoplasm with HEY1::NCOA2 fusion that is distinct from mesenchymal chondrosarcoma.
Miller TI; Mantilla JG; Wang W; Liu YJ; Tretiakova M
Genes Chromosomes Cancer; 2023 Mar; 62(3):171-175. PubMed ID: 36416671
[TBL] [Abstract][Full Text] [Related]
10. Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma.
Panagopoulos I; Gorunova L; Bjerkehagen B; Boye K; Heim S
Oncol Rep; 2014 Jul; 32(1):40-4. PubMed ID: 24839999
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal chondrosarcoma of the head and neck with HEY1::NCOA2 fusion: A clinicopathologic and molecular study of 13 cases with emphasis on diagnostic pitfalls.
Xu B; Rooper LM; Dermawan JK; Zhang Y; Suurmeijer AJH; Dickson BC; Demicco EG; Antonescu CR
Genes Chromosomes Cancer; 2022 Nov; 61(11):670-677. PubMed ID: 35672279
[TBL] [Abstract][Full Text] [Related]
12. [Detection and analysis of HEY1-NCOA2 fusion gene in mesenchymal chondrosarcoma].
Hao YH; Luo SY; Wang DZ; Tang XB
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):616-618. PubMed ID: 32486542
[No Abstract] [Full Text] [Related]
13. HEY1-NCOA2 expression modulates chondrogenic differentiation and induces mesenchymal chondrosarcoma in mice.
Tanaka M; Homme M; Teramura Y; Kumegawa K; Yamazaki Y; Yamashita K; Osato M; Maruyama R; Nakamura T
JCI Insight; 2023 May; 8(10):. PubMed ID: 37212282
[TBL] [Abstract][Full Text] [Related]
14. Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in HEY1-NCoA2-driven mesenchymal chondrosarcoma.
Safaric Tepes P; Segovia D; Jevtic S; Ramirez D; Lyons SK; Sordella R
Lab Invest; 2022 Sep; 102(9):1038-1049. PubMed ID: 34837064
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal chondrosarcomas showing immunohistochemical evidence of rhabdomyoblastic differentiation: a potential diagnostic pitfall.
Folpe AL; Graham RP; Martinez A; Schembri-Wismayer D; Boland J; Fritchie KJ
Hum Pathol; 2018 Jul; 77():28-34. PubMed ID: 29559236
[TBL] [Abstract][Full Text] [Related]
16. OLIG2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases.
Yao K; Duan Z; Yang S; Du Z; Wang Y; Qi X
J Neuropathol Exp Neurol; 2020 Sep; 79(9):959-965. PubMed ID: 32770197
[TBL] [Abstract][Full Text] [Related]
17. Primary intradural extramedullary spinal mesenchymal chondrosarcoma: case report and literature review.
Chen CW; Chen IH; Hu MH; Lee JC; Huang HY; Hong RL; Yang SH
BMC Musculoskelet Disord; 2019 Sep; 20(1):408. PubMed ID: 31484514
[TBL] [Abstract][Full Text] [Related]
18. NKX3.1 immunohistochemistry and methylome profiling in mesenchymal chondrosarcoma: additional diagnostic value for a well-defined disease?
Glauser S; Ameline B; Andrei V; Harder D; Pauli C; Trautmann M; Hartmann W; Baumhoer D
Pathology; 2023 Aug; 55(5):621-628. PubMed ID: 37225644
[TBL] [Abstract][Full Text] [Related]
19. A mesenchymal chondrosarcoma with aberrant nuclear expression of STAT6: a potential diagnostic pitfall.
Broggi G; Mazzucchelli M; Covello R; Casini B; Barbagallo GMV; Salvatorelli L; Magro G
Pathol Res Pract; 2022 Apr; 232():153803. PubMed ID: 35217266
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology.
El Beaino M; Roszik J; Livingston JA; Wang WL; Lazar AJ; Amini B; Subbiah V; Lewis V; Conley AP
Curr Oncol Rep; 2018 Mar; 20(5):37. PubMed ID: 29582189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]